Cramer's Biotech Trend Plays

Description:

"I don't even know where to begin about the positives of the Genetech (DNA)- Roche deal. First, it confirms the general trend: the dollar is so weak that it is worth buying anything that's name-brand if you are from Europe, including Anheuser-Busch (BUD ), a total creature of the weak dollar. It confirms a second trend that the biotechs are the best buys when it comes to a bank-led slowdown. Finally, there is the sentiment issue. Every time the press has hit something during this abominable era, it has struck pay dirt. The negativity surrounding DNA was so great that even when it reported better-than-expected earnings, the stock took a hit initially until people realized that Avastin really was growing again." - Jim Cramer

Most Viewed Portfolios

View All

Articles

5 Stocks Poised for Breakouts

05.25.12 | 11:47 AM

 WINDERMERE, Fla. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, ...

8 Stocks Soaring on Big Volume

05.25.12 | 01:13 PM

WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...

More Articles

Recent Answers

Popular Forums

More Forums
blog comments powered by Disqus
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter